Cagrilintide
$116.40
Cagrilintide - Appetite Suppression & Metabolic Control
Description
Cagrilintide is a synthetic long-acting analog of amylin, a hormone co-secreted with insulin by pancreatic beta cells. Amylin plays a role in regulating postprandial glucose levels and promoting satiety. Cagrilintide is engineered to provide prolonged receptor activation compared to native amylin.
In human clinical investigations, Cagrilintide has been studied for its effects on appetite reduction, energy intake modulation, and body weight regulation. Activation of central amylin receptors influences hypothalamic and brainstem circuits involved in satiety signaling. Research domains include obesity, metabolic regulation, and combination incretin-based therapies.
Clinical Status
Human RCT ✔ | Observational ✔ | Animal ✔ | In vitro ✔
Evaluated in multiple human clinical trials for obesity and metabolic regulation research.
Mechanism of Action
Cagrilintide activates amylin receptors in the brain, promoting satiety and reducing food intake. Its long-acting design extends receptor engagement compared to native amylin.
Benefits
- Activates central amylin-mediated satiety circuits:
Cagrilintide binds to amylin receptors located in the area postrema and hypothalamic nuclei involved in appetite regulation. These regions integrate peripheral nutrient signals and translate them into satiety perception. Activation of amylin receptors influences neuronal firing patterns associated with meal termination and reduced hunger drive. Unlike appetite suppression driven by stimulant pathways, Cagrilintide works within physiologic satiety networks. This central modulation supports investigation into neuroendocrine control of food intake. - Engages calcitonin receptor–RAMP complexes for receptor specificity:
Amylin receptors are heterodimeric complexes composed of calcitonin receptors coupled with receptor activity-modifying proteins (RAMPs). Cagrilintide binds selectively to these receptor complexes, triggering intracellular signaling cascades that regulate appetite perception. This receptor architecture provides functional specificity within the central nervous system. The structural design of Cagrilintide enhances receptor engagement duration compared to native amylin, contributing to sustained signaling in experimental models. - Prolonged receptor activation through long-acting design:
Native amylin is rapidly cleared from circulation, limiting its biological effect. Cagrilintide incorporates structural modifications that extend its half-life and prolong receptor interaction. Sustained receptor engagement allows continuous activation of satiety pathways without repeated peaks and troughs. This extended activity profile differentiates it from short-acting amylin analogs and supports longer-lasting appetite modulation research frameworks. - Modulates gastric emptying and nutrient flux:
Amylin receptor activation influences gastrointestinal motility by slowing gastric emptying. Delayed nutrient delivery to the small intestine contributes to prolonged satiety and moderated postprandial glucose excursions. This peripheral mechanism complements central appetite suppression. By influencing both brain and gut signaling, Cagrilintide integrates neuroendocrine and digestive control systems. - Integrates with insulin and postprandial metabolic signaling:
Amylin is physiologically co-secreted with insulin from pancreatic beta cells. This co-secretion reflects coordinated regulation of nutrient intake and glucose handling. By mimicking amylin signaling, Cagrilintide participates in this integrated metabolic network. Its action influences appetite perception while aligning with insulin-mediated nutrient processing pathways in research models. - Demonstrates complementary action with GLP-1 pathways:
GLP-1 receptor agonists and amylin analogs operate through distinct but complementary mechanisms. GLP-1 influences insulin secretion and central appetite control, while amylin primarily modulates satiety and gastric emptying. Cagrilintide’s mechanism provides additive or synergistic potential when studied alongside incretin-based therapies. This dual-pathway engagement reflects layered neuroendocrine regulation of energy balance. - Supports structured energy intake reduction research:
By activating satiety circuits and slowing digestion, Cagrilintide reduces caloric intake in controlled experimental settings. Rather than stimulating metabolism directly, it alters upstream behavioral drivers of energy consumption. This positioning differentiates it from thermogenic compounds and places it within appetite-regulation research domains. - Operates within physiologic energy homeostasis systems:
Energy balance is maintained by coordinated signaling among leptin, insulin, GLP-1, ghrelin, and amylin. Cagrilintide integrates into this network by enhancing satiety feedback while preserving endogenous regulatory loops. Its mechanism reflects modulation of the body’s built-in energy control architecture rather than forced metabolic acceleration. - Influences brainstem-hypothalamic communication loops:
The area postrema acts as a key interface between circulating peptides and central appetite regulation. Cagrilintide’s activity within this region influences downstream hypothalamic signaling pathways. This brainstem-hypothalamic integration is central to coordinated hunger suppression and meal size reduction. Understanding this loop is essential in advanced metabolic research contexts.
Research Data
xxx
Stack Suggestions
xxx
Pen Dosage Chart
Dosage & Protocols Variations
xxx
Possible Side Effects
xxx
Product Attributes
xxx
Scientific References
xxx
Included In The Box
Every product arrives in a premium, custom-designed PEPTIDE.Power box, engineered for convenience, hygiene, and safe storage in your refrigerator. Inside, you will find everything needed for your full research protocol:
- 1× Disposable Pre-Mixed Injection Pen
- Powered by our proprietary PSM Technology™ – precision stabilization & mixing system for consistent potency
- 10× Ultra-thin Needles (33G, 4 mm)
- 10× Alcohol Pads for sterile preparation
- Internal Stabilizing Foam Insert to prevent shaking during transport
- Instruction Panel printed on the inside of the box for quick reference
- Security Seal Sticker ensuring the package has not been opened or tampered with
Storage
Store the product in a refrigerator at 1 – 7°C immediately upon delivery. To maintain optimal stability, keep the pen away from light, and do not expose it to repeated temperature changes.
Once reconstituted (all our pens come pre-mixed), research compounds remain stable for 6 – 8 weeks under proper refrigeration.
Do not freeze after reconstitution. Always keep the box closed so the pen, needles, and alcohol pads stay clean and protected.
For best results, use the product consistently within the recommended time window and always follow your research protocol.
Delivery
We ship with Next-Day EU Delivery via DHL Express or UPS Express.
All orders are prepared fresh on the day of dispatch, placed in EPS cold-chain transport boxes, and shipped with cooling elements to maintain a stable temperature throughout the journey.
Our logistics process is designed so the package arrives overnight, avoiding customs delays inside the European Union.
Products are shipped from our EU facility, ensuring no import duties, no customs clearance, and always fast and secure delivery.
Payment
Due to the nature of research peptides and the high-risk category assigned by payment processors, credit card companies do not support merchants in this field.
For this reason, we accept bank transfers only.
Within the European Union, SEPA transfers are fast, low-cost, and usually arrive within minutes to a few hours, making the payment process smooth and simple.
Once the transfer is received, your order is prepared immediately and dispatched the same day (cut-off dependent).
This method ensures compliance, security, and continuity of service for all customers across the EU.
